Literature DB >> 14663485

Mechanisms of apoptosis induction by nucleoside analogs.

Deepa Sampath1, V Ashutosh Rao, William Plunkett.   

Abstract

Nucleoside analogs are structurally, metabolically, and pharmacodynamically related agents that nevertheless have diverse biological actions and therapeutic consequences. This class of agents affects the structural integrity of DNA, generally after incorporation during replication or DNA excision repair synthesis, leading to stalled replication forks and chain termination. The DNA damage sensors ATM, ATR and DNA-PK recognize these events. These and other protein kinases activate checkpoint pathways that arrest cell cycle progression, and also signal for DNA repair. In addition, if these survival mechanisms are overwhelmed by the damage caused, a third function of these sensors is to activate signaling pathways that initiate apoptotic processes. A review of the spectrum of responses that are activated by clinically relevant nucleoside analogs begins to provide a mechanistic basis for diverse outcomes in cell viability. Such information, when coupled with an understanding of the intrinsic apoptotic potential of a tumor cell type may provide a rational basis for the design of therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14663485     DOI: 10.1038/sj.onc.1207229

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  48 in total

1.  Chidamide shows synergistic cytotoxicity with cytarabine via inducing G0/G1 arrest and apoptosis in myelodysplastic syndromes.

Authors:  Zhaoyun Liu; Jin Chen; Honglei Wang; Kai Ding; Yanqi Li; Anya de Silva; Varun Sehgal; Jonathan Lvan Burbano; Radhika Sundararaj; Janani Gamage; Victor Audu; Rong Fu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  cAMP-mediated inhibition of DNA replication and S phase progression: involvement of Rb, p21Cip1, and PCNA.

Authors:  Soheil Naderi; Jean Y J Wang; Tung-Ti Chen; Kristine B Gutzkow; Heidi K Blomhoff
Journal:  Mol Biol Cell       Date:  2005-01-12       Impact factor: 4.138

3.  Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial.

Authors:  Deepa Sampath; Jorge Cortes; Zeev Estrov; Min Du; Zheng Shi; Michael Andreeff; Varsha Gandhi; William Plunkett
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

4.  Bufalin and 5-fluorouracil synergistically induce apoptosis in colorectal cancer cells.

Authors:  Xiao-Yu Dai; Bao-Feng Zhou; Yang-Yang Xie; Jie Lou; Ke-Qiang Li
Journal:  Oncol Lett       Date:  2018-03-23       Impact factor: 2.967

Review 5.  DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment.

Authors:  S Solier; Y-W Zhang; A Ballestrero; Y Pommier; G Zoppoli
Journal:  Curr Cancer Drug Targets       Date:  2012-05       Impact factor: 3.428

6.  Anticancer effect of calycopterin via PI3K/Akt and MAPK signaling pathways, ROS-mediated pathway and mitochondrial dysfunction in hepatoblastoma cancer (HepG2) cells.

Authors:  Mohammad Ali Esmaeili; Mahdi Moridi Farimani; Mahmoud Kiaei
Journal:  Mol Cell Biochem       Date:  2014-07-25       Impact factor: 3.396

7.  Acquisition of anoikis resistance promotes the emergence of oncogenic K-ras mutations in colorectal cancer cells and stimulates their tumorigenicity in vivo.

Authors:  Mathieu Derouet; Xue Wu; Linda May; Byong Hoon Yoo; Takehiko Sasazuki; Senji Shirasawa; Janusz Rak; Kirill V Rosen
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

8.  ATM and the Mre11-Rad50-Nbs1 complex respond to nucleoside analogue-induced stalled replication forks and contribute to drug resistance.

Authors:  Brett Ewald; Deepa Sampath; William Plunkett
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

9.  Targeting the wee1 kinase for treatment of pediatric Down syndrome acute myeloid leukemia.

Authors:  J Timothy Caldwell; Holly Edwards; Steven A Buck; Yubin Ge; Jeffrey W Taub
Journal:  Pediatr Blood Cancer       Date:  2014-06-24       Impact factor: 3.167

10.  Glyceraldehyde 3-phosphate dehydrogenase depletion induces cell cycle arrest and resistance to antimetabolites in human carcinoma cell lines.

Authors:  Manali S Phadke; Natalia F Krynetskaia; Anurag K Mishra; Evgeny Krynetskiy
Journal:  J Pharmacol Exp Ther       Date:  2009-07-23       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.